Back to top

HUTCHMED (China) (HCM) Gets a Buy from UBS

In a report released on July 2, from UBS maintained a Buy rating on HUTCHMED (China) , with a price target of HK$34.10. The company’s shares closed...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HUTCHMED (China) Limited Sponsored ADR (HCM)